Follow
Bozica Kovacevic
Bozica Kovacevic
Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health
Verified email at postgrad.curtin.edu.au
Title
Cited by
Cited by
Year
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study
A Mooranian, S Raj Wagle, B Kovacevic, R Takechi, J Mamo, V Lam, ...
Scientific Reports 10 (1), 106, 2020
472020
Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies
SR Wagle, B Kovacevic, D Walker, CM Ionescu, U Shah, G Stojanovic, ...
Expert Opinion on Drug Delivery 17 (10), 1361-1376, 2020
432020
Micro-Nano formulation of bile-gut delivery: Rheological, stability and cell survival, basal and maximum respiration studies
SR Wagle, D Walker, B Kovacevic, A Gedawy, M Mikov, S Golocorbin-Kon, ...
Scientific Reports 10 (1), 7715, 2020
352020
Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 …
A Mooranian, N Zamani, R Takechi, H Al-Sallami, M Mikov, ...
Artificial Cells, Nanomedicine, and Biotechnology 46 (sup3), 748-754, 2018
342018
Pharmacological and advanced cell respiration effects, enhanced by toxic human-bile nano-pharmaceuticals of probucol cell-targeting formulations
SR Wagle, B Kovacevic, D Walker, CM Ionescu, M Jones, G Stojanovic, ...
Pharmaceutics 12 (8), 708, 2020
312020
The emerging role of bile acids as critical components in nanotechnology and bioengineering: Pharmacology, formulation optimizers and hydrogel-biomaterial applications
B Kovacevic, M Jones, C Ionescu, D Walker, S Wagle, J Chester, T Foster, ...
Biomaterials 283, 121459, 2022
262022
Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and …
A Mooranian, N Zamani, CM Ionescu, R Takechi, G Luna, M Mikov, ...
Pharmacological Reports 72, 368-378, 2020
222020
A review on recent advancement on age-related hearing loss: the applications of nanotechnology, drug pharmacology, and biotechnology
J Chester, E Johnston, D Walker, M Jones, CM Ionescu, SR Wagle, ...
Pharmaceutics 13 (7), 1041, 2021
212021
A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds
A Mooranian, N Zamani, M Mikov, S Goločorbin-Kon, G Stojanovic, ...
Saudi Pharmaceutical Journal 28 (2), 165-171, 2020
212020
Modulatory nano/micro effects of diabetes development on pharmacology of primary and secondary bile acids concentrations
A Mooranian, N Zamani, R Takechi, G Luna, M Mikov, S Goločorbin-Kon, ...
Current Diabetes Reviews 16 (8), 900-909, 2020
182020
Bio micro-nano technologies of antioxidants optimised their pharmacological and cellular effects, ex vivo, in pancreatic β-cells
A Mooranian, N Zamani, M Mikov, S Goločorbin-Kon, G Stojanovic, ...
Nanotechnology, Science and Applications, 1-9, 2020
172020
Pharmacological and biological study of microencapsulated probucol-secondary bile acid in a diseased mouse model
SR Wagle, B Kovacevic, CM Ionescu, D Walker, M Jones, L Carey, ...
Pharmaceutics 13 (8), 1223, 2021
162021
Advancements in assessments of bio-tissue engineering and viable cell delivery matrices using bile acid-based pharmacological biotechnologies
A Mooranian, M Jones, CM Ionescu, D Walker, SR Wagle, B Kovacevic, ...
Nanomaterials 11 (7), 1861, 2021
162021
Bile acid-polymer-probucol microparticles: Protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model
A Mooranian, N Zamani, G Luna, H Al-Sallami, M Mikov, ...
Pharmaceutical development and technology 24 (10), 1272-1277, 2019
162019
Pharmacological effects of secondary bile acid microparticles in diabetic murine model
A Mooranian, N Zamani, B Kovacevic, CM Ionescu, G Luna, M Mikov, ...
Current Diabetes Reviews 18 (1), 83-92, 2022
152022
Formulation buoyancy of nanoencapsulated gliclazide using primary, conjugated and deconjugated bile acids
S Mathavan, CM Ionescu, B Kovacevic, M Mikov, S Golocorbin-Kon, ...
Therapeutic Delivery 10 (9), 573-583, 2019
152019
Microencapsulation of Coenzyme Q10 and bile acids using ionic gelation vibrational jet flow technology for oral delivery
M Jones, D Walker, CM Ionescu, B Kovacevic, SR Wagle, A Mooranian, ...
Therapeutic Delivery 11 (12), 791-805, 2020
142020
Histological effects of pharmacologically active human bile acid nano/micro-particles in Type-1 diabetes
S Mathavan, CM Ionescu, B Kovacevic, M Mikov, S Golocorbin-Kon, ...
Therapeutic Delivery 11 (3), 157-171, 2020
142020
Probucol-poly (meth) acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice
A Mooranian, N Zamani, R Takechi, H Al-Sallami, M Mikov, ...
Therapeutic Delivery 10 (9), 563-571, 2019
142019
Enhanced bilosomal properties resulted in optimum pharmacological effects by increased acidification pathways
A Mooranian, T Foster, CM Ionescu, D Walker, M Jones, SR Wagle, ...
Pharmaceutics 13 (8), 1184, 2021
132021
The system can't perform the operation now. Try again later.
Articles 1–20